Department of Medicine, Hennepin County Medical Center, University of Minnesota, Minneapolis, Minn, USA.
J Thorac Cardiovasc Surg. 2010 May;139(5):1333-8. doi: 10.1016/j.jtcvs.2009.08.021. Epub 2009 Oct 23.
Patients on dialysis sustain at least a threefold higher in-hospital mortality rate and markedly higher long-term mortality following coronary artery bypass graft surgery than the general population. Smaller studies have suggested that dialysis patients have superior outcomes with off-pump compared with on-pump coronary artery bypass surgery.
From the United States Renal Data System database, 13,085 patients on dialysis having first coronary artery bypass surgery between 2001 and 2006 were identified. Of these, 2335 (17.8%) had off-pump coronary artery bypass surgery. The Kaplan-Meier method was used to estimate survival of patients having off-pump coronary artery bypass and patients having on-pump coronary artery bypass. A Cox proportional hazards model was used to assess effects of off-pump coronary artery bypass on mortality with adjustment for baseline patient characteristics.
Off-pump coronary artery bypass surgery was associated with significantly reduced all-cause mortality compared with on-pump coronary artery bypass surgery (hazard ratio 0.92, 95% confidence interval 0.86-0.99, P = .02). The observed survival benefit was most notable in the first year after surgery (70.3% vs 68.7%) and was lost 2 years after surgery (55.4% vs 55.2%). No difference was noted in the in-hospital mortality rate with off-pump coronary artery bypass surgery versus on-pump coronary artery bypass surgery (9.7% vs 11.0%, P = .06). Cardiac mortality during the follow-up period was similar (23.6% vs 23.8%; adjusted hazard ratio 0.95, 95% confidence interval 0.86-1.04, P = .26). Use of internal thoracic grafts was independently associated with improved survival after coronary artery bypass surgery (hazard ratio, 0.92; 95% confidence interval, 0.87-0.98, P = .0057).
Patients on dialysis sustain high in-hospital and 2-year mortality rates after coronary artery bypass surgery. Off-pump coronary artery bypass is associated with modestly increased survival compared with on-pump coronary artery bypass, a benefit most marked early after off-pump coronary artery bypass.
与普通人群相比,透析患者在接受冠状动脉旁路移植手术后的院内死亡率高出至少三倍,且长期死亡率也显著更高。一些较小的研究表明,与体外循环冠状动脉旁路移植术相比,非体外循环冠状动脉旁路移植术可使透析患者获得更好的结果。
从美国肾脏数据系统数据库中确定了 2001 年至 2006 年间首次接受冠状动脉旁路移植术的 13085 名透析患者。其中 2335 名(17.8%)患者接受了非体外循环冠状动脉旁路移植术。采用 Kaplan-Meier 方法估计行非体外循环冠状动脉旁路移植术和行体外循环冠状动脉旁路移植术患者的生存情况。采用 Cox 比例风险模型评估非体外循环冠状动脉旁路移植术对死亡率的影响,同时调整基线患者特征。
与体外循环冠状动脉旁路移植术相比,非体外循环冠状动脉旁路移植术显著降低了全因死亡率(风险比 0.92,95%置信区间 0.86-0.99,P =.02)。术后第一年观察到的生存获益最为显著(70.3% vs 68.7%),术后 2 年丧失(55.4% vs 55.2%)。非体外循环冠状动脉旁路移植术与体外循环冠状动脉旁路移植术的院内死亡率无差异(9.7% vs 11.0%,P =.06)。随访期间的心脏死亡率相似(23.6% vs 23.8%;调整后的风险比 0.95,95%置信区间 0.86-1.04,P =.26)。使用内乳动脉移植物与冠状动脉旁路移植术后生存改善独立相关(风险比 0.92;95%置信区间 0.87-0.98,P =.0057)。
透析患者在接受冠状动脉旁路移植手术后会出现高院内死亡率和 2 年死亡率。与体外循环冠状动脉旁路移植术相比,非体外循环冠状动脉旁路移植术可使患者的生存率略有提高,这种获益在非体外循环冠状动脉旁路移植术后早期最为显著。